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Background: There is abundant literature on how to distinguish problem gambling (PG) from social gambling, but
there are very few studies of the long-term evolution of gambling practice. As a consequence, the correlates of key
state changes in the gambling trajectory are still unknown. The objective of the JEU cohort study is to identify the
determinants of key state changes in the gambling practice, such as the emergence of a gambling problem, natural
recovery from a gambling problem, resolution of a gambling problem with intermediate care intervention, relapses
or care recourse.
Methods/design: The present study was designed to overcome the limitations of previous cohort study on PG.
Indeed, this longitudinal case–control cohort is the first which plans to recruit enough participants from different
initial gambling severity levels to observe these rare changes. In particular, we plan to recruit three groups of
gamblers: non-problem gamblers, problem gamblers without treatment and problem gamblers seeking treatment.
Recruitment takes place in various gambling places, through the press and in care centers.
Cohort participants are gamblers of both sexes who reported gambling on at least one occasion in the previous year
and who were aged between 18 and 65. They were assessed through a structured clinical interview and self-assessment
questionnaires at baseline and then once a year for five years. Data collection comprises sociodemographic
characteristics, gambling habits (including gambling trajectory), the PG section of the DSM-IV, the South Oaks
Gambling Screen, the Gambling Attitudes and Beliefs Survey – 23, the Mini International Neuropsychiatric
Interview, the Wender-Utah Rating Scale-Child, the Adult ADHD Self-report Scale, somatic comorbidities (especially
current treatment and Parkinson disease) and the Temperament and Character Inventory – 125.
Discussion: The JEU cohort study is the first study which proposes to identify the predictive factors of key state
changes in gambling practice. This is the first case–control cohort on gambling which mixes non-problem gamblers,
problem gamblers without treatment and problem gamblers seeking treatment in almost equal proportions. This work
may help providing a fresh perspective on the etiology of pathological gambling, which may provide support for future
research, care and preventive actions.
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Pathological Gambling (PG) is a behavioral addiction
characterized by a loss of control over gambling which
then becomes the subject’s only interest, prevailing over
all his/her other activities, causing serious harmful con-
sequences to social, family, or financial life. The preva-
lence of lifetime PG is estimated at around 0.4-1.0% [1].
There is abundant literature on how to distinguish
problem gambling from social gambling [2-6], but there
are very few studies of the long-term evolution of gam-
bling practice, even though this study design is the only
one which can identify protective and risk factors for PG
[7]. We can mention the study by Slutske in 2003 [8],
from which the main lesson is that gambling problems
are often transient and episodic rather than continuous
and chronic. Other studies confirmed that a status of
pathological gambler is unstable over time (16–19). An-
other cohort study by Nelson et al. [9] showed that the
onset of gambling and gambling problems occurs later
in women, but they seek treatment sooner. Another im-
portant result is that the earlier initiation occurs, the
longer the time between initiation and recourse to treat-
ment, for both genders. Although these studies are par-
ticularly interesting for understanding the gambling
trajectory, they have several limitations. The main one is
the limited samples used (students [8], pathological gam-
blers in treatment [9], males from 45 to 60 years old
[10], young adults [11], casino employees [12], etc.).
Those populations are not representative of the gam-
blers’ population as a whole. There are very few samples
that combine both non-problem gamblers, problem
gamblers who are not undergoing treatment and prob-
lem gamblers seeking treatment, in sufficient propor-
tions for analysis of the gambling trajectory. Moreover,
these studies did not try to identify the protection or
risk factors which determine changes of state in the
gambling trajectory. The majority of studies only report
the description and prevalence of these state changes,
but do not look for a causal effect between certain
psychosocial correlates and changes over time. When
these studies explored these state changes in greater de-
tail, they were limited by the restricted number of prob-
lem gamblers in their samples, making it difficult to
observe the changes [13]. Moreover, most of the studies
that attempted to explore the natural history of gam-
bling used retrospective data, collected cross-sectionally
[9,10,13]. Longitudinal studies are still rare, and are sub-
ject to the other above-mentioned limitations [12] or do
not explore all the possible state changes [14]. Finally,
most of these studies are based exclusively on self-
reported measurements of gambling practice and PG
symptoms [9-11].
Therefore, the correlates of key state changes in the gam-
bling trajectory are still unknown. The overall objective ofthe JEU cohort study is to understand how and why a gam-
bling practice evolves. The study aims:
(1) to explore and describe the gambling population,
especially specific profiles based on: their
sociodemographics (especially gender), their
gambling habits (gambling trajectory, gambling
activities, gambling-related cognitions, etc.) and
their psychiatric comorbidities (including Attention
Deficit Hyperactivity Disorder (ADHD)).
(2) to compare gamblers at baseline, depending on
whether they are problem or non-problem gamblers,
and included or not in a treatment program. The
aim of doing this is to isolate factors which may
differ depending on the presence of a gambling
problem and the recourse to treatment, to test them
as potential determinants of the evolution of the
gambling practice.
(3) to identify longitudinal predictors of five key state
changes: emergence of a gambling problem, natural
recovery from a gambling problem, resolution of a
gambling problem with intermediate care
intervention, relapses and recourse to treatment.
Methods/design
Setting of the study – consortium
This cohort was established in 2009 and is coordinated by
two researchers (first and last author) from the Clinical
Investigation Unit BALANCED “BehaviorAL AddictioNs
and ComplEx mood Disorders” at the University Hospital
of Nantes and the SPHERE research team “bioStatistics,
Pharmacoepidemiology and Human sciEnces Research
tEam” at the University of Nantes. The University Hos-
pital of Nantes is the sponsor of this study. The study
involves a group of French clinicians and researchers
from seven French institutions which have a care offer
or a research area dedicated to PG (Northwestern:
University Hospital of Nantes associated with University
of Nantes; Southwestern: University of Bordeaux associ-
ated with Charles Perrens Hospital of Bordeaux; Paris
region: University of Paris Ouest Nanterre La Défense
associated with Louis Mourier Hospital of Colombes,
Marmottan Medical Center in Paris, Paul Brousse University
Hospital of Villejuif; Southeastern: Sainte-Marguerite
University Hospital of Marseille; Center: University Hospital
of Clermont-Ferrand).
Study design
The present study was designed to overcome the limita-
tions of previous cohort study on PG. In particular, it
was very important to have enough participants in the
initial groups to observe these rare changes. We thus
designed a longitudinal case–control cohort, which was
divided in two phases:
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and compare three groups: Non-Problem Gamblers
(NPG), Problem Gamblers Without Treatment (PGWT)
and Problem Gamblers Seeking Treatment (PGST). This
phase consists of a baseline assessment.
Phase 2 is the key step of the study which aims to study
the differential long course development of NPGs and
PGWTs. This longitudinal part of the study consists of five
years prospective follow-up. Since the future of problem
gamblers in care was not one of our objectives, PGSTs
were not included in the longitudinal follow-up. By fol-
lowing the evolution of socio-demographic and clinical
variables in addition to these state changes, we will be able
to identify the predictive factors of these state changes. An
illustration of the study design is given in Figure 1.
Ethical approval
Participants were informed about the research and gave
their written informed consent prior to their inclusion in
the study. This study was approved by the French Re-
search Ethics Committee (CPP) on January 8, 2009. The
approval granted from the CPP applies to all sites where
the study takes place.
Participants
Gamblers of both sexes who reported gambling on at
least one occasion during the previous year, and agedBaseline assessment





Non-Problem Gamblers (NPG) 
Problem Gamblers Without Treatment (PGWT) 
Problem Gamblers Seeking Treatment (PGST) 
(PGSTs are not included in the longitudinal follow-up) 
April 2010                                         
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 Emergence of a gambling pr
Recourse to treatment 
 Natural recovery from a gam
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Figure 1 Study design.between 18 and 65 were eligible for the study. Exclusion
criteria were severe cognitive or communication impair-
ment and guardianship. Recruitment took place between
April 2009 and September 2011, in five regions of
France (Northwest, Southwest, Paris region, Center and
Southeast). NPGs and PGWTs were recruited in various
gambling places (casinos, cafés, smoke shops, etc.) and
through the press, in order to obtain the broadest pos-
sible range of gambling severity levels and gambling ac-
tivities. PGSTs were recruited in seven care centers.
Participation in the study was proposed during the in-
clusion period to each new patient and to patients who
had started treatment less than six months before. Of
the 628 eligible volunteers who agreed to take part in
the study, 206 were recruited in care centers, 195 in
gambling places and 227 through the press.
Sample size
The computation of the number of subjects to be in-
cluded was based on the assumption that the presence
of psychiatric comorbidities was a determining factor in
the evolution of gambling practice. Thus, for phase 1,
the inclusion of between 500 and 680 subjects was
intended to highlight a minimum difference of three
psychiatric comorbidities between groups, with a power
of at least 90% and a bilateral risk α of 5%. For phase 2,
information from the scientific literature and cohortPhase 2 : 
Longitudinal follow-up 
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the time of study design to allow us to estimate correctly
the probability of state changes. As a consequence, a for-
mal computation of the number of subjects required in
follow-up wasn’t performed. Because of the low preva-
lence of gambling problems in the general population,
the sample was constituted based on a predetermined
and approximate equality of size between NPGs, PGWTs
and PGSTs (that is between 160 and 260 participants
per group).
Procedure
A baseline assessment is performed just after inclusion
in the study. The proposed assessment mixes a clinical
structured interview carried out with a trained re-
searcher or psychologist with a set of standardized self-
report questionnaires. Participants realize the baseline
interview in the research center or the gambling place in
which they were recruited. Participants from the initial
NPG and PGWT groups are followed up for 5 years after
their inclusion. Participants are contacted once each year
on the anniversary date of the last completed assessment
(plus or minus 2 months). The follow-up interview is of-
fered by phone or at the research center, depending on
the availability and desire of the participant. The object-
ive is to propose simple follow-up modalities to maintain
the highest number of participants in the study. If a
follow-up assessment does not take place, the reason is
postponed (unreachable, refusal to continue, or death).
For unreachability, a participant is considered to have
withdrawn from the study only if two consecutive as-
sessments are missing. Each assessment (baseline and
follow-up assessments) comprises almost the same ques-
tionnaire content, which is described below.
Measures
Inclusion of variables to be monitored over time
The final choice of clinical and gambling-related vari-
ables to be monitored over time was based on discus-
sions with the teams participating in the project (JEU
group) and a review of the literature. We chose to re-
strict the assessment procedure to a limited number of
questionnaires, in an attempt to reduce the duration of
the assessment to a maximum of one thirty. We ex-
pected that the shorter the duration of the assessment,
the more the procedure would be accepted by the gam-
blers, especially PGWTs who are particularly difficult to
recruit for research purposes.
The proposed assessment content was tested in a pre-
liminary feasibility study, in particular within the popu-
lation of gamblers recruited in gambling places. This
study allowed us to estimate the human resources
needed to achieve effective recruitment set (inclusion
period of a year per center), and favor interview modalitieswith the lowest rate of missing data (interview in the
research center).
The final set of questionnaires includes socio-demographic
characteristics, gambling-related data, psychiatric and
somatic comorbidities, ADHD antecedents and personal-
ity profile. The complete assessment content is detailed in
Table 1.
Categorization between problem and non-problem
gamblers
The distinction between problem and non-problem
gamblers was achieved through an interview based on
the DSM-IV [15] 10 diagnostic criteria for PG. Gamblers
who met at least three DSM-IV criteria were classified as
problem gamblers (including both gamblers “at risk” for
pathological gambling and gamblers with a diagnosis of
PG), and those remaining as non-problem gamblers. We
used a non-standard threshold of three instead of five to
include subclinical forms of PG. Previous literature has
supported the relevance of this categorization [16-18].
The number of positive DSM IV criteria for pathological
gambling is also used as a dimensional score of gambling
problem severity and the responses to each criterion is
taken into account to study the various symptoms of
pathological gambling.
Gambling-related characteristics
Participants were asked about participation in various
forms of gambling over the past year, monthly gambling
expenditure especially in relation to income, maximum
wagering in a single day, age at which they were initiated
into gambling and family history of problem gambling.
They were also invited to determine their preferred gam-
bling activity, i.e. the one which they preferred among all
the gambling activities they have experimented in their
lives (gamblers with a multi-game profile were restricted
to defining a single preferred gambling activity). They
also completed two self-report questionnaires related to
gambling. The South Oaks Gambling Screen (SOGS)
[19] is used to assess the severity of gambling problems.
The Gambling Attitudes and Beliefs Survey (GABS) [20]
is used to assess irrational beliefs and attitudes about
gambling. The GABS-23 [21] is a revised version of
the original GABS which consists of 23 items divided
into 5 dimensions: Strategies, Chasing, Attitudes, Luck
and Emotions.
Psychiatric and somatic comorbidities
The main axis-I psychiatric disorders were explored with
the Mini International Neuropsychiatric Interview (MINI
5.0) [22]. It includes assessment of the major anxiety
disorders, mood disorders (plus current risk of suicide),
addictive disorders and to a lesser extent psychotic disor-
ders. Somatic comorbidities were explored by asking the
Table 1 Content of the multiaxial assessment for each
phase of follow-up
Phase Measurements
Baseline NPG, PGWT and PGST Informed written consent
Clinical structured interview
(lifetime and past year):
-Sociodemographic characteristics
-PG section of DSM-IV (diagnosis
of a gambling problem)
-Gambling habits




-SOGS (self-reported severity of
gambling problems)
-GABS-23 (gambling-related cognitions)
-TCI-125 (temperament and character
dimensions)
-WURS-C (screening of ADHD in
childhood)
-ASRS-1.1 (screening of ADHD in
adulthood)





-PG section of DSM-IV (diagnosis of a
gambling problem)
-Gambling habits (without gambling
course)








-TCI-125 (only character dimensions,
i.e. 65 items)
Ongoing All participants are monitored using
routine data sources providing deaths
and study dropouts (unreachable or
refusal to continue) since baseline.
Notes:
NPG = non-problem gamblers, PGWT = problem gamblers without treatment,
PGST = problem gamblers seeking treatment.
PG = pathological gambling.
ADHD = Attention Deficit Hyperactivity Disorder.
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders.
MINI = Mini International Neuropsychiatric Interview – fifth version.
SOGS = South Oaks Gambling Screen.
GABS-23 = Gambling Attitudes and Beliefs Survey - Revised version.
TCI-125 = Temperament and Character Inventory – 125.
WURS-C = Wender-Utah Rating Scale-Child.
ASRS-1.1 = Adult ADHD Self-report Scale.
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somatic pathologies (especially dopaminergic medications
for Parkinson disease [23-25] and aripiprazole for schizo-
phrenia or bipolar disorder [26,27]).
ADHD antecedents
Two self-report questionnaires are used to screen
ADHD in the sample. The Wender-Utah Rating Scale-
Child (WURS-C) [28,29] is used to make a retrospective
screening of ADHD in childhood, and is supplemented
by the Adult ADHD Self-report Scale (ASRS-v1.1)
[30,31] which screens ADHD in adulthood.
Personality profile
The shorter 125-item version of the Temperament and
Character Inventory (TCI-125) [32,33] is used to rapidly
explore the seven dimensions of personality defined
by Cloninger’s psychobiological model [32]. The TCI-
125 assesses four temperament traits (Novelty Seeking,
Harm Avoidance, Reward Dependence and Persistence)
and three character traits (Self-Directedness, Cooper-
ation and Self-Transcendence). Moreover, the optional
section for antisocial personality disorder of the MINI
[22] is also used to make a diagnosis of antisocial per-
sonality disorder. It will not be taken into account for
the calculation of the number of psychiatric comorbidi-
ties (which is one of our major hypothetic predictor of
the gambling practice evolution), since it is not an axis I
psychiatric comorbidity but an element of personality
(Axis II).
Outcome measures
The primary outcome measures for the JEU cohort are
change in gambling status (problem or non-problem
gambling) and recourse to treatment. The presence of
a gambling problem is assessed annually with the 10
criteria from the DSM-IV (see above). Recourse to treat-
ment is also assessed annually through one question:
“Did you consult a health professional for a gambling
problem in the past twelve months?”. A change in one
of these two measures during the follow-up is consid-
ered as a state change in the gambling history.
Analysis
Descriptive analysis of all the variables collected at base-
line will be provided, for the whole sample and per
group. A summary of the major characteristics of the
sample at baseline is shown in Table 2. Description of
loss of follow-up (drop-out, missing data) will also be
provided, especially reasons for drop-out.
In order to evaluate the evolution of the status of the
gamblers, we will analyze data using a multistate Markov
model (with 2 possible states -problem or non-problem
gamblers- or 3 possible states –NPG, PGWT or PGST).
Table 2 Major characteristics of the JEU Cohort (n = 628) at baseline
N (responders) % M (SD)
SOCIODEMOGRAPHICS
Gender (males) 628 66.6%
Age (years) 627 43.4 (12.9)
Monthly income (€) 623 1739.1 (1957.4)
Professional activity (working) 627 63.5%
Marital status (living alone) 627 49.9%
GAMBLING-RELATED CHARACTERISTICS
Gambling status 628
Non-Problem Gamblers (NPG) 40.8%
Problem Gamblers without Treatment (PGWT) 26.9%
Problem Gamblers Seeking Treatment (PGST) 32.3%
Preferred gambling activity 628




Lottery games with differed results (Loto® 1, Euromillions® 2, Kéno ® 1) 11.1%
Sports betting 7.6%
Roulette 3.8%
Lottery games with instant results (Rapido® 3, online Bingo) 2.5%
Black Jack 0.5%
Non classified (name given too sketchy) 2.1%
Frequency of gambling (once a week or more) 628 76.0%
Monthly gambling expenditure (€) 621 592.7 (1494.4)
Proportion of income spent on gambling 612 35.3%
Maximum amount wagered in one day (€) 605 1275.2 (5349.0)
Age of initiation into gambling 628 20.4 (9.3)
Age of onset of a regular gambling practice 584 26.4 (11.4)
Age of onset of gambling problems (PGWT and PGST only) 350 34.7 (11.7)
Age of first consultation for gambling problems (PGST only) 196 40.1 (11.3)
Internet as the favorite medium of gambling 571 12.6%
Experience of abstinence for one month or more 627 62.7%
Family aware of the gambling problem 418 72.7%
Familial history of gambling problems 605 25.5%
PSYCHIATRIC AND SOMATIC COMORBIDITIES
Mood disorders4 628 47.6%
Anxiety disorders5 628 37.9%
Addictive disorders6 628 35.2%
Psychotic syndrome 627 8.0%
Actual suicidal risk 628 23.7%
Parkinson’s disease 627 1.1%
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Table 2 Major characteristics of the JEU Cohort (n = 628) at baseline (Continued)
ADHD antecedents
ADHD screening in childhood (WURS-C) 599 20.7%




Novelty Seeking 52.6 (18.0)
Harm Avoidance 43.9 (23.4)






Antisocial personality disorder 628 3.4%
Notes:1Loto® and Kéno® are two national lotteries in France.
2Euromillions is the European lottery.
3Rapido® is a French game available in bars. The goal is to find 8 out of 20 numbers in a first grid (grid A) and simultaneously a number of four (grid B). The draw
frequency of Rapido® is very high, with one draw every two and a half minutes.
4Mood disorders included: depressive disorders (major depressive episodes or dysthymia) and manic or hypomanic episodes.
5Anxiety disorders included: panic disorder, agoraphobia, social phobia, obsessive-compulsive disorder, post-traumatic stress disorder and generalized anxiety disorder.
6Addictive disorders included: substance use disorders, alcohol-use disorders and eating disorders.
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blers will be studied.
In order to identify longitudinal predictors of the key
state changes, we will use mixed linear models allowing
taking into account the correlation between the different
measures of the patients among times of measurement.
Factors predicting variation of time until the key state
change will be identified using these models.
Discussion
The mixing of non-problem gamblers and problem gam-
blers who have not yet sought treatment is one of the
main strengths of our cohort. Problem gamblers who have
not yet sought treatment constitute a very rare population
in PG research, although they form the key transit state
between non-problem gambling and problem gambling
with care. Moreover, as noted previously, samples of gam-
blers assessed over a five-year follow-up are very rare in
the literature. The few existing cohort studies have several
limitations and fail to identify protective and risk factors
which would determine changes of state in the gambling
trajectory. It is essential to understand such changes in
order to provide appropriate prevention or care programs,
and improve our understanding of PG etiology. Our co-
hort is the first one which is designed to observe the state
changes in the gambling trajectory and link them with
psychosocial correlates monitored over time, in order
to identify the predictive factors of these changes in aprospective and longitudinal manner. Another strength
and originality of the project lies in its recruitment of
gamblers outside specialized care centers and not only
through media or advertising. We also included recruit-
ment directly from the usual gambling places, for about
a third of our sample (31%). This method gave us access
to a broad spectrum of gambling activities and varying
initial levels of gambling practice. Finally, the overall
sample size (628) has rarely been achieved for studies with
semi-structured interviews (most of the time, studies with
such high numbers of participants are telephone-based
surveys). Our study design is all the more relevant in
that the assessment combines a structured face-to-face
interview with self-report questionnaires. Moreover, the
monitoring of loss of follow-up over time indicates that
the current follow-up participation is just under 60% for
the first and second year assessments, and seemed to in-
crease after that (see Additional file 1 for more details).
Refusals to continue were the main reason for dropouts
during the first-year assessment, and unreachability for
the second-year assessment. This result was expected
because unreachability was defined as having missed
two consecutive follow-up. We expect that the follow-up
participation of the third-year and following assessments
will increase, because the least motivated participants have
withdrawn during the previous steps. However, a partici-
pation rate of this order is already a high one for a cohort
of this type [34,35].
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cially the restricted amount of data collected. Indeed,
some data, which may have had an influence on state
changes, were not collected (for example, impulsivity,
gambling motivation, etc.). However, we chose to restrict
the assessment procedure to a limited number of ques-
tionnaires, in an attempt to maximize the acceptation
of the procedure by the gamblers. Since recruitment
methods were diversified (via the press and in gambling
venues), it is also conceivable that the participation of
follow-up will be different between gamblers recruited
by these different methods. In addition, it could be en-
visaged that gamblers pursuing or not the follow-up are
different populations and that it could possibly bias the
results from follow-up data. To verify these possible lim-
itations, we conducted a preliminary analysis to compare
participants who withdrew and those who were still in
the follow-up on April 30, 2014, that is exactly five years
after the first inclusion in the study (detailed results are
given in Additional file 2). Participants who withdrew
were younger, had a shorter experience of gambling, and
gambled more on the Internet. We presume that the
younger age explains the shorter experience of gambling
(the difference in age is equivalent to the difference in
gambling experience) and preference for Internet. It is
well-known that the younger the participants, the less
persistent they are and the more likely they are to have
experienced changes in their living conditions (entry into
working life, marriage, relocation, etc.). It is thus not
surprising that the younger ones are those who most
often withdraw from the study. The other main differ-
ence was the mode of recruitment. Participants who are
still in the follow-up were much more likely to have
been recruited through the press. We expected this
result because participants who were recruited via the
press had taken the step of contacting us, while for
others we took the initiative in approaching them in their
gambling places to ask them to participate. No other dif-
ference in sociodemographics, gambling habits or psychi-
atric comorbidities was found between participants who
withdrew and those who were still in the follow-up, indi-
cating that the cohort is consistent over time.
Finally, the case–control design of our cohort implies
that our sample is not representative of the general
population of gamblers (in terms of prevalence of prob-
lem gambling in particular). However, the aim was to
observe changes of state in gambling practice, and not
to establish the prevalence of gambling problems. It was
therefore very important to have enough participants in
the initial groups to observe these rare changes and thus
overcome the limitations mentioned in previous studies
[13]. In order to estimate if our sample was closed to
the general population, especially in terms of socio-
demographic data, we compared the socio-economics ofour sample (n = 628) with those of the French national
prevalence survey (n = 25 034) [36] (see Additional file 3
for more details). Gamblers from the JEU cohort study
shared some socioeconomic characteristics with gam-
blers from the national prevalence survey. The few dif-
ferences observed were probably due to the fact that
problem gamblers were artificially over-represented in
the JEU cohort study (59.2% against 0.3% in the national
prevalence survey), while it is a case–control study.Conclusions
The JEU cohort study is the first study which proposes
to identify the predictive factors of key state changes in
gambling practice, such as the emergence of a gambling
problem, natural recovery from a gambling problem, reso-
lution of a gambling problem with intermediate care inter-
vention, relapses or care recourse, using a prospective and
longitudinal approach. This is the first case–control co-
hort on gambling which mixes non-problem gamblers,
problem gamblers without treatment and problem gam-
blers seeking treatment in almost equal proportions. We
believe that this work may help providing a fresh perspec-
tive on the etiology of pathological gambling, which may
provide support for future research, care and preventive
actions in the field of gambling.Additional files
Additional file 1: Loss of follow-up on April 30, 2014 (five years
after first inclusion in the study).
Additional file 2: Comparisons between participants who dropped
out and those who were still in follow-up on April 30, 2014 (five
years after first inclusion in the study)a.
Additional file 3: Socioeconomics of the JEU Cohort (n = 628)
compared with gamblers from French national prevalence survey
data (n = 25 034) [36].Abbreviations
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